Kelly Lawrence W & Associates’s Vertex Pharmaceuticals VRTX Stock Holding History

Kelly Lawrence W & Associates’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$269K	Hold	605	–	–	0.07%	67
2025 Q1	$293K	Hold	605	–	–	0.07%	71
2024 Q4	$244K	Hold	605	–	–	0.06%	76
2024 Q3	$281K	Sell	605 -700	-54%	-$326K	0.06%	76
2024 Q2	$612K	Sell	1,305 -153	-10%	-$71.7K	0.14%	53
2024 Q1	$609K	Sell	1,458 -10	-0.7%	-$4.18K	0.14%	51
2023 Q4	$597K	Hold	1,468	–	–	0.14%	53
2023 Q3	$510K	Hold	1,468	–	–	0.14%	55
2023 Q2	$503K	Hold	1,468	–	–	0.13%	56
2023 Q1	$463K	Sell	1,468 -140	-9%	-$44.1K	0.13%	59
2022 Q4	$464K	Sell	1,608 -500	-24%	-$144K	0.13%	58
2022 Q3	$610K	Hold	2,108	–	–	0.17%	52
2022 Q2	$594K	Hold	2,108	–	–	0.16%	53
2022 Q1	$550K	Sell	2,108 -20	-0.9%	-$5.22K	0.12%	55
2021 Q4	$468K	Hold	2,128	–	–	0.09%	57
2021 Q3	$386K	Hold	2,128	–	–	0.08%	59
2021 Q2	$429K	Hold	2,128	–	–	0.09%	59
2021 Q1	$457K	Buy	2,128 +1,341	+170%	+$288K	0.11%	61
2020 Q4	$186K	Sell	787 -1,766	-69%	-$417K	0.07%	52
2020 Q3	$695K	Buy	2,553 +20	+0.8%	+$5.45K	0.21%	41
2020 Q2	$735K	Sell	2,533 -5,195	-67%	-$1.51M	0.15%	41
2020 Q1	$1.84M	Sell	7,728 -550	-7%	-$131K	0.45%	34
2019 Q4	$1.81M	Sell	8,278 -545	-6%	-$119K	0.28%	37
2019 Q3	$1.5M	Sell	8,823 -215	-2%	-$36.4K	0.25%	40
2019 Q2	$1.66M	Sell	9,038 -735	-8%	-$135K	0.28%	38
2019 Q1	$1.8M	Sell	9,773 -1,429	-13%	-$263K	0.32%	38
2018 Q4	$1.86M	Sell	11,202 -125	-1%	-$20.7K	0.4%	37
2018 Q3	$2.18M	Sell	11,327 -500	-4%	-$96.4K	0.36%	43
2018 Q2	$2.01M	Sell	11,827 -1,520	-11%	-$258K	0.37%	42
2018 Q1	$2.18M	Sell	13,347 -6,955	-34%	-$1.13M	0.41%	42
2017 Q4	$3.04M	Sell	20,302 -405	-2%	-$60.7K	0.56%	40
2017 Q3	$3.15M	Sell	20,707 -380	-2%	-$57.8K	0.6%	40
2017 Q2	$2.72M	Hold	21,087	–	–	0.54%	42
2017 Q1	$2.31M	Buy	21,087 +2	+0%	+$219	0.48%	43
2016 Q4	$1.55M	Sell	21,085 -77,080	-79%	-$5.68M	0.34%	46
2016 Q3	$8.56M	Sell	98,165 -20	-0%	-$1.74K	1.83%	26
2016 Q2	$8.45M	Buy	+98,185	New	+$8.45M	1.95%	25